M. S. Lin

401 citations
15 papers · 315 · h-index 8

Impact in

Papers in

M. S. Lin

15 papers receiving 286 citations

Peers

M. S. Lin
Comparison fields: 5 of 79
  • Pharmacology 45
  • Pharmacology 78
  • Toxicology 11
  • Cardiology and Cardiovascular Medicine 63
  • Nephrology 17
Replace Ryuichi Ogawa with:
Ryuichi Ogawa Japan
L.‐C. Chu United States
G Lévy United States
J. A. Wojtulewski United Kingdom
E.‐H. Egberts Germany
A. Pottage United Kingdom
A Escousse France
S Lucchi Italy
Yukiko Yoda Japan
Patrick Mayo Canada
M. S. Lin relative to Ryuichi Ogawa Japan Ryuichi Ogawa's profile →
Citations per field
00.5×3.7×
Ryuichi Ogawa · 1×
Citations per year

Countries citing papers authored by M. S. Lin

Since Specialization
Citations

This map shows the geographic impact of M. S. Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. S. Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. S. Lin more than expected).

Fields of papers citing papers by M. S. Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. S. Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. S. Lin. The network helps show where M. S. Lin may publish in the future.

Co-authors

The 9 scholars most cited alongside M. S. Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with M. S. Lin Line = papers co-authored together M. S. Lin links everyone, so they are left out of the graph.

All Works

15 of 15 papers shown
#Work
1 1982120
2 200559
3 198146
4 198115
5 201215
6 198314
7 198313
8 19819
9 19817
10
Determination of acetylator phenotype in hypertensive patients with renal impairment
19825
11
Comparisons of long-term effects of lisinopril vs nifedipine vs conventional therapy in the treatment of mild-to-moderate hypertension in patients with chronic obstructive pulmonary disease.
19965
12 20213
13
A-1. Dose-independent hydralazine pharmacokinetics after intravenous administration to hypertensive patients
19812
14
Relationships between plasma hydralazine (H) concentrations and hypotensive response in patients
19791
15
Discordant effects of nitroprusside and hydralazine on heart rate and plasma norepinephrine concentration
19821

About M. S. Lin

M. S. Lin is a scholar working on Cardiology and Cardiovascular Medicine, Pharmacology, Cellular and Molecular Neuroscience, Pharmacology and Surgery, having authored 15 papers that have together received 315 indexed citations. Recurring topics across this work include Blood Pressure and Hypertension Studies (4 papers), Neuropeptides and Animal Physiology (3 papers), Pharmacogenetics and Drug Metabolism (2 papers), Heart Rate Variability and Autonomic Control (2 papers), Analytical Methods in Pharmaceuticals (2 papers), Diet and metabolism studies (1 paper), Cardiac electrophysiology and arrhythmias (1 paper) and Eicosanoids and Hypertension Pharmacology (1 paper). The work is most often cited by research in Pharmacology (45 citations), Pharmacology (78 citations), Toxicology (11 citations), Cardiology and Cardiovascular Medicine (63 citations) and Nephrology (17 citations). M. S. Lin has collaborated with scholars based in United States, Taiwan and United Kingdom. Frequent co-authors include Alexander M. M. Shepherd, J. L. McNay, Thomas M. Ludden, Yung‐Hsiang Chen, Raoh‐Fang Pwu, Yang-Shia Dai, T. Kent Keeton, Чиа-Чи Ченг and Ying Huang. Their work appears in journals such as Hypertension, Clinical Pharmacology & Therapeutics, Annals of Internal Medicine, Clinical Pharmacokinetics and Internal Medicine Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact